QUATTROVAC

This brand name is authorized in Japan

Active ingredients

The drug QUATTROVAC contains a combination of these active pharmaceutical ingredients (APIs):

1 Pertussis toxin
Read about Pertussis toxoid
2 Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
3 Diphtheria toxoid
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
Read about Diphtheria toxoid
4 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
5 Inactivated poliovirus type 1 (Sabin strain)
UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 1
6 Inactivated poliovirus type 2 (Sabin strain)
UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 2
7 Inactivated poliovirus type 3 (Sabin strain)
UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 3

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: JP 医薬品医療機器総合機構 Identifier(s): 636140DG2028

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈